Congress Asset Management CO Editas Medicine, Inc. Transaction History

Congress Asset Management CO

  • $13.6 Billion
  • Q1 2024

A detailed history of Congress Asset Management CO transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Congress Asset Management CO holds 91,631 shares of EDIT stock, worth $441,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91,631
Previous 90,439 1.32%
Holding current value
$441,661
Previous $916,000 25.87%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024
BUY
$7.03 - $11.07 $8,379 - $13,195
1,192 Added 1.32%
91,631 $679,000
Q4 2023

Mar 04, 2024
BUY
$6.25 - $11.11 $1,281 - $2,277
205 Added 0.23%
90,439 $916,000
Q3 2023

Nov 01, 2023
BUY
$6.92 - $9.31 $830 - $1,117
120 Added 0.13%
90,234 $703,000
Q2 2023

Jul 27, 2023
BUY
$6.36 - $11.47 $3,593 - $6,480
565 Added 0.63%
90,114 $741,000
Q1 2023

Apr 21, 2023
BUY
$7.03 - $11.53 $62,159 - $101,948
8,842 Added 10.96%
89,549 $649,000
Q4 2022

Jan 18, 2023
BUY
$8.32 - $13.21 $5,308 - $8,427
638 Added 0.8%
80,707 $0
Q3 2022

Nov 08, 2022
BUY
$12.16 - $19.42 $12,208 - $19,497
1,004 Added 1.27%
80,069 $980,000
Q2 2022

Aug 02, 2022
BUY
$9.99 - $21.35 $6,213 - $13,279
622 Added 0.79%
79,065 $935,000
Q1 2022

Apr 20, 2022
BUY
$14.08 - $27.63 $107,951 - $211,839
7,667 Added 10.83%
78,443 $1.49 Million
Q4 2021

Jan 28, 2022
BUY
$26.55 - $40.57 $557 - $851
21 Added 0.03%
70,776 $1.88 Million
Q3 2021

Nov 08, 2021
BUY
$39.27 - $72.94 $105,047 - $195,114
2,675 Added 3.93%
70,755 $2.91 Million
Q2 2021

Aug 05, 2021
BUY
$31.29 - $56.64 $326,667 - $591,321
10,440 Added 18.11%
68,080 $3.86 Million
Q1 2021

May 05, 2021
BUY
$39.71 - $90.58 $2.29 Million - $5.22 Million
57,640 New
57,640 $2.42 Million

Others Institutions Holding EDIT

# of Institutions
243
Shares Held
69.3M
Call Options Held
564K
Put Options Held
428K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $331M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email